Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LGVN
LONGEVERON INC.
NASDAQ
$6.72
▼ DOWN 1.18% (-0.08)

KEY STATISTICS

Market Cap$20.45 M
52w High$12.30
52w Low$4.75
Dividend Yield—
Frequency—
P/E-6.79
Volume79.67K
Shares Out.3.04M

COMPANY

LEADERSHIP

Stephen H. Willard
CHIEF EXECUTIVE
Stephen H. Willard

COMPENSATION 2026

Salary$194,386
Stock Awards$112,225
Incentive Plan Pay$135,550
All Other Comp.$23,031
Total$475,824

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 12, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
38

PRICE TARGET

Target High$10.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.00

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$400.00K
NOV
3
TUE

SPLIT RECORD

DATETYPERATIO
2026-08-27Reverse1:10
2024-03-27Reverse1:10

PRICE

$6.72 ▼ DOWN 1.18% (−$0.08)
OVERLAYS
$6.60$6.75$6.909:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM6.72

About Longeveron Inc.

https://www.longeveron.com ↗

Longeveron Inc. is a Miami-based biotech company developing cellular therapies, including LOMECEL-B, derived from young donor bone marrow, for aging-related and life-threatening conditions in Phase 1 and 2 trials.

INDUSTRY

Biotechnology

A PRODUCT LONGEVERON INC. IS KNOWN FOR

Lomecel-B (laromestrocel)
Lomecel-B (laromestrocel)

Lomecel-B is an off-the-shelf allogeneic cell therapy from young donor bone marrow, in clinical trials for aging-related diseases, HLHS, and Alzheimer's.

COMPETITORS

COMPETITOR
BCLI COMPARE
CAPR COMPARE
MESO COMPARE
PLUR COMPARE
VCEL COMPARE

Revenue by Products

IconPRODUCTQ1-2021
AlzheimersAssociationGrantMember$170K
ClinicalTrialRevenueMember$165K
MarylandTEDCOGrantMember$41K

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 361.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
72.26%
HOLDERS
40
TOP 12 OF 40 · RANKED BY POSITION SIZE
Vanguard Group Inc
505.6K sh · $379.18K
Millennium Management LLC
446.7K sh · $464.59K
Blackrock, Inc.
224.2K sh · $233.17K
Geode Capital Management, LLC
203.6K sh · $211.76K
Adar1 Capital Management, LLC
200.0K sh · $208K
Jane Street Group, LLC
185.7K sh · $193.08K
Hrt Financial LP
118.9K sh · $123K
Beacon Pointe Advisors, LLC
100.0K sh · $104K
Ubs Group AG
64.0K sh · $47.99K
Renaissance Technologies LLC
56.6K sh · $42.46K
Northern Trust Corp
48.4K sh · $24.49K
State Street Corp
45.4K sh · $22.96K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Jhaveri Nirav S.
— · —
2026-08-17
★
OFFICER: CHIEF FINANCIAL OFFICER
Jhaveri Nirav S.
Purchase · 300.0K shares
2026-08-17
★
DIRECTOR
Paletta George A. Jr.
Purchase · 36.0K shares
2026-08-19
★
DIRECTOR
Ungaro Ursula
Purchase · 36.0K shares
2026-08-19

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 1
BUY 1
2 GRADES IN THE LAST 12 MONTHS
Maxim Group HOLD HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
PALI$2.00COMPARE
DARE$0.73COMPARE
CTXR$0.60COMPARE
PCSA$2.06COMPARE
PULM$1.51COMPARE
FBLG$1.44COMPARE
CRIS$1.49COMPARE
ASBP$8.51COMPARE